Treatment of asthma with glucocorticosteroids

Robert Nelson, Richard F. Lockey

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Glucocorticosteroids (GCS) are used to treat asthma that does not respond to accepted first-line therapy. Because they have potent anti-inflammatory properties, facilitate β-adrenergic responsiveness, suppress the late-phase reaction and reduce secretion of mucus, GCS are indicated in the treatment of severe acute asthma and chronic asthma not responsive to beta-agonists and methylxanthines. They are also useful as a diagnostic tool to determine reversibility of airway obstruction in some patients with chronic obstructive pulmonary disease. Maximal antiasthmatic effect is achieved by prescribing daily divided doses of intermediate-acting systemic GCS and reducing the dosage to alternate days after the asthma has been controlled. Inhaled GCS have minimal systemic effects when used properly, and in selected cases may be as effective as the oral preparations. Improper use of these drugs may provoke, side effects which are undesirable and dangerous. Proper patient education in the use of these drugs is necessary to avoid such severe adverse effects.

Original languageEnglish (US)
Pages (from-to)761-769
Number of pages9
JournalSouthern Medical Journal
Volume81
Issue number6
StatePublished - 1988
Externally publishedYes

Fingerprint

Asthma
Anti-Asthmatic Agents
Airway Obstruction
Patient Education
Mucus
Therapeutics
Pharmaceutical Preparations
Adrenergic Agents
Chronic Obstructive Pulmonary Disease
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of asthma with glucocorticosteroids. / Nelson, Robert; Lockey, Richard F.

In: Southern Medical Journal, Vol. 81, No. 6, 1988, p. 761-769.

Research output: Contribution to journalArticle

Nelson, R & Lockey, RF 1988, 'Treatment of asthma with glucocorticosteroids', Southern Medical Journal, vol. 81, no. 6, pp. 761-769.
Nelson, Robert ; Lockey, Richard F. / Treatment of asthma with glucocorticosteroids. In: Southern Medical Journal. 1988 ; Vol. 81, No. 6. pp. 761-769.
@article{5d00e8fb3d0a402ab81be3c3d601b575,
title = "Treatment of asthma with glucocorticosteroids",
abstract = "Glucocorticosteroids (GCS) are used to treat asthma that does not respond to accepted first-line therapy. Because they have potent anti-inflammatory properties, facilitate β-adrenergic responsiveness, suppress the late-phase reaction and reduce secretion of mucus, GCS are indicated in the treatment of severe acute asthma and chronic asthma not responsive to beta-agonists and methylxanthines. They are also useful as a diagnostic tool to determine reversibility of airway obstruction in some patients with chronic obstructive pulmonary disease. Maximal antiasthmatic effect is achieved by prescribing daily divided doses of intermediate-acting systemic GCS and reducing the dosage to alternate days after the asthma has been controlled. Inhaled GCS have minimal systemic effects when used properly, and in selected cases may be as effective as the oral preparations. Improper use of these drugs may provoke, side effects which are undesirable and dangerous. Proper patient education in the use of these drugs is necessary to avoid such severe adverse effects.",
author = "Robert Nelson and Lockey, {Richard F.}",
year = "1988",
language = "English (US)",
volume = "81",
pages = "761--769",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Treatment of asthma with glucocorticosteroids

AU - Nelson, Robert

AU - Lockey, Richard F.

PY - 1988

Y1 - 1988

N2 - Glucocorticosteroids (GCS) are used to treat asthma that does not respond to accepted first-line therapy. Because they have potent anti-inflammatory properties, facilitate β-adrenergic responsiveness, suppress the late-phase reaction and reduce secretion of mucus, GCS are indicated in the treatment of severe acute asthma and chronic asthma not responsive to beta-agonists and methylxanthines. They are also useful as a diagnostic tool to determine reversibility of airway obstruction in some patients with chronic obstructive pulmonary disease. Maximal antiasthmatic effect is achieved by prescribing daily divided doses of intermediate-acting systemic GCS and reducing the dosage to alternate days after the asthma has been controlled. Inhaled GCS have minimal systemic effects when used properly, and in selected cases may be as effective as the oral preparations. Improper use of these drugs may provoke, side effects which are undesirable and dangerous. Proper patient education in the use of these drugs is necessary to avoid such severe adverse effects.

AB - Glucocorticosteroids (GCS) are used to treat asthma that does not respond to accepted first-line therapy. Because they have potent anti-inflammatory properties, facilitate β-adrenergic responsiveness, suppress the late-phase reaction and reduce secretion of mucus, GCS are indicated in the treatment of severe acute asthma and chronic asthma not responsive to beta-agonists and methylxanthines. They are also useful as a diagnostic tool to determine reversibility of airway obstruction in some patients with chronic obstructive pulmonary disease. Maximal antiasthmatic effect is achieved by prescribing daily divided doses of intermediate-acting systemic GCS and reducing the dosage to alternate days after the asthma has been controlled. Inhaled GCS have minimal systemic effects when used properly, and in selected cases may be as effective as the oral preparations. Improper use of these drugs may provoke, side effects which are undesirable and dangerous. Proper patient education in the use of these drugs is necessary to avoid such severe adverse effects.

UR - http://www.scopus.com/inward/record.url?scp=0024026948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024026948&partnerID=8YFLogxK

M3 - Article

C2 - 3287642

AN - SCOPUS:0024026948

VL - 81

SP - 761

EP - 769

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 6

ER -